Dahap, Clark T.

HRN: 28-75-57  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2026
CEFUROXIME 750MG (VIAL)
03/27/2026
04/03/2026
IV
345MG
Q8
T/C Pcap C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: